[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  Neumora Therapeutics, Inc. Common Stock (NMRA) NMRA stock plunges amid analyst downgrades and market downturn, despite some predicting a price increase. High social media engagement reports losses. ### About Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock (NMRA) is a publicly traded stock in the healthcare sector. Neumora Therapeutics, Inc. Common Stock uses the ticker $NMRA for trading. Listed in the [Stocks](/list/stocks) and category. ### Insights [#](/topic/$nmra/insights) - Neumora Therapeutics, Inc. Common Stock (NMRA) galaxy score™ is up XXXXXX% from the previous month. - Neumora Therapeutics, Inc. Common Stock (NMRA) engagements is up XXXXXX% from the previous week. ### Price: $XXXX [#](/topic/$nmra/close) ---  [Price 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/close.tsv) The stock price is declining due to a combination of negative analyst ratings, a general market downturn, and negative sentiment from social media users reporting losses. The high social media engagement, with numerous posts mentioning stock losses, further contributes to the downward pressure on the stock price. | 24-Hour | 7-Day | | ------- | ----- | | XXX% | -XXXX% | **1-Year High**: $XXXXX on 2024-10-21 **1-Year Low**: $XXXXX on 2025-05-14 ### AltRank: XXXXX [#](/topic/$nmra/alt_rank) ---  [AltRank 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/alt_rank.tsv) Neumora Therapeutics, Inc. Common Stock (NMRA) is currently AltRank #2,141 based on combined combined social and market metrics **Daily Average**: XXX **1 Week**: XXXXX +950 **1 Month**: XXXXX +1,605 **6 Months**: XXXXX +1,696 **1 Year**: XXXXX +1,555 **1-Year High**: XXXXX on 2025-09-25 **1-Year Low**: XX on 2024-12-07 ### Galaxy Score: XXXXX [#](/topic/$nmra/galaxy_score) ---  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/galaxy_score.tsv) **Current Value**: XXXXX **Daily Average**: XX **1 Week**: XX +10 **1 Month**: XX +31 **6 Months**: XX +5 **1 Year**: XX +20 **1-Year High**: XX on 2025-07-09 **1-Year Low**: X on 2025-04-04 ### Engagements: X [#](/topic/$nmra/interactions) ---  [Engagements 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/interactions.tsv) **Current Value**: X **Daily Average**: XXXXX **1 Week**: XXXXX +177% **1 Month**: XXXXX -XX% **6 Months**: XXXXXXX -XX% **1 Year**: XXXXXXXXX +177% **1-Year High**: XXXXXXX on 2024-12-13 **1-Year Low**: X on 2025-10-11 | Social Network | X | | -------------- | - | | Engagements | X | ### Mentions: X [#](/topic/$nmra/posts_active) ---  [Mentions 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: XX **6 Months**: XXX -XX% **1 Year**: XXXXX +224% **1-Year High**: XXX on 2025-01-02 **1-Year Low**: X on 2025-09-07 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$nmra/contributors_active) ---  [Creators 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/contributors_active.tsv) X unique social accounts have posts mentioning Neumora Therapeutics, Inc. Common Stock (NMRA) in the last XX hours which is down XX% from X in the previous XX hours **Daily Average**: XX **6 Months**: XXX -X% **1 Year**: XXXXX +214% **1-Year High**: XXX on 2025-01-06 **1-Year Low**: X on 2025-09-07 ### Sentiment: % [#](/topic/$nmra/sentiment) ---  [Sentiment 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/sentiment.tsv) **Current Value**: % **Daily Average**: XX% **1 Month**: XX% -X% **6 Months**: XX% +42% **1 Year**: XX% -XX% **1-Year High**: XXX% on 2025-03-16 **1-Year Low**: XX% on 2024-12-19 ### Social Dominance: XXXXXXXXXXXXXXXXXXXXX% [#](/topic/$nmra/social_dominance) ---  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/social_dominance.tsv) **Current Value**: XXXXXXXXXXXXXXXXXXXXX% **Daily Average**: XXXXX% **1 Week**: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX% **1 Month**: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXXX% **6 Months**: XXXXXXX% -XXXXXXX% **1 Year**: XXXXXXX% -XXXXX% **1-Year High**: XXXXX% on 2025-01-02 **1-Year Low**: XXXXXX% on 2025-09-07 ### Market Dominance: XXXXXXXXXXXXXXXXXXXXX% [#](/topic/$nmra/market_dominance) ---  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/market_dominance.tsv) **Current Value**: XXXXXXXXXXXXXXXXXXXXX% **Daily Average**: X% **1-Year High**: XXXXXXX% on 2025-03-31 **1-Year Low**: XXXXXXX% on 2025-05-14 ### Market Cap: $XXXXXXXXXXX [#](/topic/$nmra/market_cap) ---  [Market Cap 24-Hour Time-Series Raw Data](/topic/$nmra/time-series/market_cap.tsv) **Current Value**: $XXXXXXXXXXX **Daily Average**: $XXXXXXXXXXX **1 Week**: $XXXXXXXXXXX -$6.40% **1 Month**: $XXXXXXXXXXX -$1.70% **6 Months**: $XXXXXXXXXXX +$146% **1 Year**: $XXXXXXXXXXX -$89% **1-Year High**: $XXXXXXXXXXXXX on 2024-10-21 **1-Year Low**: $XXXXXXXXXX on 2025-05-14 **Top assets mentioned** In the posts about Neumora Therapeutics, Inc. Common Stock in the last XX hours [Lithium Americas Corp. Common Shares (LAC)](/topic/$lac) [SAVE (SLND)](/topic/$slnd) [Karuna Therapeutics, Inc. Common Stock (KRTX)](/topic/$krtx) [Cere Network (CERE)](/topic/cere-network) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) **Top topics mentioned** In the posts about Neumora Therapeutics, Inc. Common Stock in the last XX hours [coins defi](/topic/coins-defi), [$200m2b](/topic/$200m2b), [$lac](/topic/$lac), [$fofo](/topic/$fofo), [$slnd](/topic/$slnd), [$krtx](/topic/$krtx), [cere network](/topic/cere-network), [coins made in usa](/topic/coins-made-in-usa), [momentum](/topic/momentum), [$amdy](/topic/$amdy), [$trt](/topic/$trt), [$crnx](/topic/$crnx) ### Top Social Posts [#](/topic/$nmra/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Momentum surged across the Oct XX tape as multiple growth names triggered fresh bullish 50/200 SMA crossovers. $AMDY led with a XX% rally on volume doubling dayoverday while $TRT gained XX% with a XXX% jump in activity. $CRNX and $NMRA also confirmed clean crossovers supported by sustained liquidity signaling renewed strength across midcap biotech and industrials. The fourday volume trend screen highlighted relentless accumulation. $DGNX advanced XX% on nearly XX% higher volume while $ONCO and $JETD posted tripledigit percentage increases in turnover showing consistent inflows. $YXI and $DSGN" [X Link](https://x.com/tradesviz/status/1978071559806812643) [@tradesviz](/creator/x/tradesviz) 2025-10-14T12:13Z 39.8K followers, XXX engagements "After Hours Smallcaps ($200M-2B) Gainers Losers $LAC +32% $FOFO -XX% $SLND +28% $SLDE -XX% $IRWD +12% $UFG -XXX% $EGAN +8.5% $ENTA -XXX% $PEPG +6.1% $LWAY -XXX% $NN +5.2% $SIGA -X% $EGHT +4.7% $AVDL -X% $TRVI +4.3% $RPAY -XXX% $TMQ +4.3% $NMRA -XXX% $SMRT +4.3% $MLTX -XXX% $TWIN +4.1% $SSII -XXX% $VSTS +4.1% $AIIO -XXX% $RZLV +3.8% $AHCO -XXX% $BZAI +3.8% $EWTX -XXX% $MAMA +3.8% $SEPN -3.4%" [X Link](https://x.com/MarketCap_Live/status/1973154176998973496) [@MarketCap_Live](/creator/x/MarketCap_Live) 2025-09-30T22:33Z XXX followers, XXX engagements "I wonder if folks at $NMRA look at clinical data. Touting a more specific M4 Currently the one lesson learned from comparing data from $KRTX vs $CERE was that M4 specificity wasnt beneficial. Who knows but perhaps $NMRA given prior performance should omit the hyperbole" [X Link](https://x.com/bluejaunt100/status/1942908878447910990) [@bluejaunt100](/creator/x/bluejaunt100) 2025-07-09T11:29Z XXX followers, 2816 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Neumora Therapeutics, Inc. Common Stock (NMRA)
NMRA stock plunges amid analyst downgrades and market downturn, despite some predicting a price increase. High social media engagement reports losses.
About Neumora Therapeutics, Inc. Common Stock
Neumora Therapeutics, Inc. Common Stock (NMRA) is a publicly traded stock in the healthcare sector.
Neumora Therapeutics, Inc. Common Stock uses the ticker $NMRA for trading. Listed in the Stocks and category.
Insights #
- Neumora Therapeutics, Inc. Common Stock (NMRA) galaxy score™ is up XXXXXX% from the previous month.
- Neumora Therapeutics, Inc. Common Stock (NMRA) engagements is up XXXXXX% from the previous week.
Price: $XXXX #
Price 24-Hour Time-Series Raw Data
The stock price is declining due to a combination of negative analyst ratings, a general market downturn, and negative sentiment from social media users reporting losses. The high social media engagement, with numerous posts mentioning stock losses, further contributes to the downward pressure on the stock price.
| 24-Hour | 7-Day |
|---|---|
| XXX% | -XXXX% |
1-Year High: $XXXXX on 2024-10-21
1-Year Low: $XXXXX on 2025-05-14
AltRank: XXXXX #
AltRank 24-Hour Time-Series Raw Data
Neumora Therapeutics, Inc. Common Stock (NMRA) is currently AltRank #2,141 based on combined combined social and market metrics
Daily Average: XXX
1 Week: XXXXX +950
1 Month: XXXXX +1,605
6 Months: XXXXX +1,696
1 Year: XXXXX +1,555
1-Year High: XXXXX on 2025-09-25
1-Year Low: XX on 2024-12-07
Galaxy Score: XXXXX #
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
1 Week: XX +10
1 Month: XX +31
6 Months: XX +5
1 Year: XX +20
1-Year High: XX on 2025-07-09
1-Year Low: X on 2025-04-04
Engagements: X #
Engagements 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XXXXX
1 Week: XXXXX +177%
1 Month: XXXXX -XX%
6 Months: XXXXXXX -XX%
1 Year: XXXXXXXXX +177%
1-Year High: XXXXXXX on 2024-12-13
1-Year Low: X on 2025-10-11
| Social Network | X |
|---|---|
| Engagements | X |
Mentions: X #
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: XX
6 Months: XXX -XX%
1 Year: XXXXX +224%
1-Year High: XXX on 2025-01-02
1-Year Low: X on 2025-09-07
| Social Network | X |
|---|---|
| Mentions | X |
Creators: X #
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning Neumora Therapeutics, Inc. Common Stock (NMRA) in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: XX
6 Months: XXX -X%
1 Year: XXXXX +214%
1-Year High: XXX on 2025-01-06
1-Year Low: X on 2025-09-07
Sentiment: % #
Sentiment 24-Hour Time-Series Raw Data
Current Value: %
Daily Average: XX%
1 Month: XX% -X%
6 Months: XX% +42%
1 Year: XX% -XX%
1-Year High: XXX% on 2025-03-16
1-Year Low: XX% on 2024-12-19
Social Dominance: XXXXXXXXXXXXXXXXXXXXX% #
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXX%
Daily Average: XXXXX%
1 Week: XXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
1 Month: XXXXXXX% -XXXXXXXXXXXXXXXXXXXXXX%
6 Months: XXXXXXX% -XXXXXXX%
1 Year: XXXXXXX% -XXXXX%
1-Year High: XXXXX% on 2025-01-02
1-Year Low: XXXXXX% on 2025-09-07
Market Dominance: XXXXXXXXXXXXXXXXXXXXX% #
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXXXXXXXXXXXXXXXX%
Daily Average: X%
1-Year High: XXXXXXX% on 2025-03-31
1-Year Low: XXXXXXX% on 2025-05-14
Market Cap: $XXXXXXXXXXX #
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXX
Daily Average: $XXXXXXXXXXX
1 Week: $XXXXXXXXXXX -$6.40%
1 Month: $XXXXXXXXXXX -$1.70%
6 Months: $XXXXXXXXXXX +$146%
1 Year: $XXXXXXXXXXX -$89%
1-Year High: $XXXXXXXXXXXXX on 2024-10-21
1-Year Low: $XXXXXXXXXX on 2025-05-14
Top assets mentioned In the posts about Neumora Therapeutics, Inc. Common Stock in the last XX hours
Lithium Americas Corp. Common Shares (LAC) SAVE (SLND) Karuna Therapeutics, Inc. Common Stock (KRTX) Cere Network (CERE) Crinetics Pharmaceuticals, Inc. (CRNX)
Top topics mentioned In the posts about Neumora Therapeutics, Inc. Common Stock in the last XX hours
coins defi, $200m2b, $lac, $fofo, $slnd, $krtx, cere network, coins made in usa, momentum, $amdy, $trt, $crnx
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Momentum surged across the Oct XX tape as multiple growth names triggered fresh bullish 50/200 SMA crossovers. $AMDY led with a XX% rally on volume doubling dayoverday while $TRT gained XX% with a XXX% jump in activity. $CRNX and $NMRA also confirmed clean crossovers supported by sustained liquidity signaling renewed strength across midcap biotech and industrials. The fourday volume trend screen highlighted relentless accumulation. $DGNX advanced XX% on nearly XX% higher volume while $ONCO and $JETD posted tripledigit percentage increases in turnover showing consistent inflows. $YXI and $DSGN"
X Link @tradesviz 2025-10-14T12:13Z 39.8K followers, XXX engagements
"After Hours Smallcaps ($200M-2B) Gainers Losers $LAC +32% $FOFO -XX% $SLND +28% $SLDE -XX% $IRWD +12% $UFG -XXX% $EGAN +8.5% $ENTA -XXX% $PEPG +6.1% $LWAY -XXX% $NN +5.2% $SIGA -X% $EGHT +4.7% $AVDL -X% $TRVI +4.3% $RPAY -XXX% $TMQ +4.3% $NMRA -XXX% $SMRT +4.3% $MLTX -XXX% $TWIN +4.1% $SSII -XXX% $VSTS +4.1% $AIIO -XXX% $RZLV +3.8% $AHCO -XXX% $BZAI +3.8% $EWTX -XXX% $MAMA +3.8% $SEPN -3.4%"
X Link @MarketCap_Live 2025-09-30T22:33Z XXX followers, XXX engagements
"I wonder if folks at $NMRA look at clinical data. Touting a more specific M4 Currently the one lesson learned from comparing data from $KRTX vs $CERE was that M4 specificity wasnt beneficial. Who knows but perhaps $NMRA given prior performance should omit the hyperbole"
X Link @bluejaunt100 2025-07-09T11:29Z XXX followers, 2816 engagements